XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.22.4

SHAREHOLDERS’ EQUITY (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
SCHEDULE OF OPTION ACTIVITY | Information regarding the Non-Plan Options for the two years ended October 31, 2022 is as follows: SCHEDULE OF OPTION ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |
Options Outstanding at October 31, 2020 |  |  | 1,698,000 |  |  | $ | 2.58 |
Exercised |  |  | (56,000 | ) |  | $ | 2.58 |
Options Outstanding October 31, 2021 |  |  | 1,642,000 |  |  | $ | 2.58 |
Exercised |  |  | (1,642,000 | ) |  | $ | 2.58 |
Options Outstanding and Exercisable at October 31, 2022 |  |  | - |  |  |  |  |
SCHEDULE OF WARRANTS ACTIVITY | Information regarding the Company’s warrants for the two years ended October 31, 2022 is as follows: SCHEDULE OF WARRANTS ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Warrants Outstanding at October 31, 2020 |  |  | 560,000 |  |  | $ | 4.71 |  |  |  |  |
Issued |  |  | 300,000 |  |  | $ | 6.56 |  |  |  |  |
Warrants Outstanding at October 31, 2021 |  |  | 860,000 |  |  | $ | 5.36 |  |  |  |  |
Issued |  |  | 60,000 |  |  | $ | 4.77 |  |  |  |  |
Exercised |  |  | (60,000 | ) |  | $ | 2.06 |  |  |  |  |
Expired |  |  | (560,000 | ) |  | $ | 4.71 |  |  |  |  |
Warrants Outstanding and Exercisable at October 31, 2022 |  |  | 300,000 |  |  | $ | 6.56 |  |  | $ | 0 |
Two Thousand Ten Plan [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
SCHEDULE OF OPTION ACTIVITY | SCHEDULE OF OPTION ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Options Outstanding at October 31, 2020 |  |  | 1,907,534 |  |  | $ | 2.82 |  |  |  |  |
Exercised |  |  | (178,500 | ) |  | $ | 2.75 |  |  |  |  |
Expired |  |  | (10,400 | ) |  | $ | 4.57 |  |  |  |  |
Options Outstanding at October 31, 2021 |  |  | 1,718,634 |  |  | $ | 2.82 |  |  |  |  |
Exercised |  |  | (212,000 | ) |  | $ | 2.68 |  |  |  |  |
Expired |  |  | (5,134 | ) |  | $ | 3.63 |  |  |  |  |
Options Outstanding and Exercisable at October 31, 2022 |  |  | 1,501,500 |  |  | $ | 2.83 |  |  | $ | 4,156,000 |
SCHEDULE OF OUTSTANDING AND EXERCISABLE | The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE
Range of Exercise Prices |  |  | Number Outstanding and Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
$ | 0.67 - $2.27 |  |  |  | 477,500 |  |  |  | 3.78 |  |  | $ | 1.46 |
$ | 2.58 - $3.13 |  |  |  | 515,000 |  |  |  | 2.38 |  |  | $ | 2.78 |
$ | 3.46 - $5.30 |  |  |  | 509,000 |  |  |  | 5.54 |  |  | $ | 4.17 |
2018 Plan [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
SCHEDULE OF OPTION ACTIVITY | SCHEDULE OF OPTION ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Options Outstanding at October 31, 2020 |  |  | 4,346,661 |  |  | $ | 3.69 |  |  |  |  |
Granted |  |  | 4,490,000 |  |  | $ | 3.82 |  |  |  |  |
Exercised |  |  | (33,888 | ) |  | $ | 3.81 |  |  |  |  |
Expired |  |  | (1,392,781 | ) |  | $ | 3.70 |  |  |  |  |
Options Outstanding at October 31, 2021 |  |  | 7,409,992 |  |  | $ | 3.76 |  |  |  |  |
Granted |  |  | 1,430,000 |  |  | $ | 2.74 |  |  |  |  |
Exercised |  |  | (22,620 | ) |  | $ | 3.15 |  |  |  |  |
Options Outstanding at October 31, 2022 |  |  | 8,817,372 |  |  | $ | 3.60 |  |  | $ | 17,644,000 |
Options Exercisable at October 31, 2022 |  |  | 5,219,039 |  |  | $ | 3.57 |  |  | $ | 10,331,000 |
SCHEDULE OF OUTSTANDING AND EXERCISABLE | The following table summarizes information about stock options outstanding under the 2018 Share Plan as of October 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE
|  |  | Options Outstanding |  |  | Options Exercisable |
Range of Exercise Prices |  |  | Number Outstanding |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |  |  | Number Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
$ | 2.09-$3.87 |  |  |  | 5,347,372 |  |  |  | 7.41 |  |  | $ | 3.24 |  |  |  | 3,927,095 |  |  |  | 6.85 |  |  | $ | 3.40 |
$ | 3.96-$5.30 |  |  |  | 3,470,000 |  |  |  | 7.98 |  |  | $ | 4.16 |  |  |  | 1,291,944 |  |  |  | 7.07 |  |  | $ | 4.09 |
Common Stock Warrant [Member] |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
SCHEDULE OF OUTSTANDING AND EXERCISABLE | The following table summarizes information about the Company’s outstanding and exercisable warrants as of October 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE
Range of Exercise Prices |  |  | Number Outstanding and Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
$ | 6.56 |  |  |  | 300,000 |  |  |  | 3.39 |  |  | $ | 6.56 |

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=ANIX_TwoThousandTenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=ANIX_TwoThousandEighteenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=ANIX_CommonStockWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |